ArchiveDynamic vapor sorption(DVS) technology is served as a crucial tool for the examination of pharmaceutical crystal forms and co-crystals. Not only can DVS technology assess moisture sorption performance of an API, but it also probes into phase transition issues, co-crystal screening, quantification of amorphous content at low levels in crystalline materials, as well as the miscellaneous. At present, many countries and regions have included DVS technology into their pharmacopoeias for the exploration of water-solid interactions. However, the Chinese pharmacopoeia has not recorded this technology. This paper provides an overview of the application and advance of DVS technology in the investigation of pharmaceutical crystal forms and co-crystals, as a reference for related research on polymorphism of drugs.
Vaginal drug delivery has attracted great attention due to its advantages such as rich blood supply, large surface area of vagina and avoidance of the hepatic first-pass effect. However, there are still issues such as leakage and discomfort in application of traditional drug dosage forms for vaginal administration. At present, strategies such as bioadhesive materials, thermosensitive materials, pH responsive materials, mucosal penetration techniques and nano technologies have been proposed to improve the retention time, permeability, and release characteristics of drugs in the vagina. Based on the physiological structure and characteristics of the vagina, this review summarizes the delivery strategies and techniques of drug delivery through the vaginal mucosa, hoping to provide a reference for the development of vaginal topical medication and uterine-targeting delivery products.
With the increasing number of drug resistant bacteria, antibacterial vaccines, as substitutes for antibiotics, have received wide attention in preventing bacterial infections. Traditional antibacterial vaccines such as the bacillus Calmette-Guérin vaccine, meningococcal polysaccharide vaccine, and pneumococcal conjugate vaccine have been successfully applied to this day, but they also have their own limitations. This situation has driven the development of novel antibacterial vaccines. This review describes the immune characteristics of traditional and new antibacterial vaccines, as well as the clinical marketing of several antibacterial vaccines, in order to provide references for the development of antibacterial vaccines.
(R)-3-aminobutanol[(R)-1] was a versatile intermediate of several drugs, and it was of great significance to optimize its synthetic process. According to a patent, the final product was (S)-3-aminobutanol instead of the required (R)-product if prepared with (R)-α-phenethylamine[(R)-3] as the chiral auxiliary agent. So, with (S)-3 as the chiral auxiliary agent, compound (R)-3-[[(S)-1-phenylethyl]amino]butan-1-ol[(R)-5] and (S)-5 were prepared by the reductive amination of 4-hydroxy-2-butanone(2), and then (R)-5 and (S)-5 were transformed into the corresponding hydrochlorides. After that, compounds 5 hydrochloride was isolated by recrystallization with a mixed solvent of ethanol and ethyl acetate (volume ratio=3∶1). After alkalization, compound 5 was underwnt the de-benzylation with palladium charcoal and ammonium formate to obtain compound 1 with a total yield of 56.04%(based on 2), a purity of 98.5% and ee of 99%.
In order to effectively control the quality of naltrexone hydrochloride, seven related substances were synthesized in this study: 17-(1-butenyl)-4,5-epoxy-3,14-dihydroxymorphine-6-one(related substance C), bis-naltrexone(related substance D), 3-cyclopropylmethoxy-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxymorphine-6-one(related substance E), 17-n-butyl-4,5-epoxy-3,14-dihydroxymorphine-6-one(related substance H), 17-(cyclopropylmethyl)-3-methoxyl-4,5-epoxy-14-hydroxymorphine-6-one(related substance J),17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphin-7-ene-6-one(related substance K), naltrexone nitrogen oxide(related substance L). The related substances K and L were not included in European pharmacopoeia 10.0. The synthetic routes of substances C, D and H had not been reported. The structures of these compounds were confirmed by MS, 1H NMR and 13C NMR.
Palivizumab(Synagis) is a classic drug used to prevent respiratory syncytial virus(RSV). Its application is limited due to its high price. In this study, a Chinese hamster ovary cell line(CHO cells) was engineered to produce palivizumab biosimilars. The key parameters of cell culture were optimized by response surface methodology, and media combinations were screened to increase yield. The results showed that a 16-days cell culture process using AM01-AF02 medium as the basal-feed combination, seeding at 5.0×106 cells per milliliter, and temperature shift from 37 ℃ to 33.0 ℃ on day 7 improved palivizumab production by 69.3% in shake flask and 30.0% in 3 L bioreactor. The purification process at a 3 L bioreactor scale was also studied, which provided a reference for the subsequent process development of palivizumab biosimilars.
The aim of this study was to investigate the feasibility of using polyethylene glycol(PEG) distearate as liquid crystalline(LC) materials to prepare drug-loaded LC nanoparticles(LCNPs). Two LC materials, mPEG distearate(mPEG350-DS) and PEG distearate(S-PEG400-S), were respectively synthesized. Both obtained derivatives could form lyotropic LC in water, and the LC of S-PEG400-S could be stably dispersed to prepare LCNPs. With docetaxel as the model drug, the LCNPs with good drug-loading capacity were obtained by adding appropriate amount of lecithin into the formula. The particle size, ζ potential, encapsulation efficiency, loading capacity, and content of the docetaxel-loaded LCNPs were 137.9 nm, –19.7 mV, 96.5%, 3.4%, and 98.2% of the labeled amount(namely 2 mg/mL), respectively. The docetaxel-loaded LCNPs showed better antitumor effects and remarkably longer blood circulation time than the commercially available injection(Taxotere®) in in vitro antitumor experiment and in vivo pharmacokinetic study. The LC phase in the LCNPs was inferred to be sponge(L3) phase according to the observations of polarizing microscopy, small angle X-ray scattering and cryo-transmission electron microscopy. In conclusion, the S-PEG400-S showed a good prospect for LCNPs-based drug delivery system.
The neck gasket is the core component of the container and closure system for metered dose inhaler(MDI). When the neck gasket has been exposed to the liquid organic excipients for a long time, gasket swelling will directly affect the rate of environmental moisture ingress into the sealing system and indirectly affect the impurity level of the drug. In this study, industrial computerized tomography(CT) technology was used to detect gasket swelling behavior of the marketed beclometasone dipropionate inhalation aerosol samples in the upright and inverted orientations in the long-term stability test, and critical quality attributes such as delivered dose per actuation, fine particles dose(FPD), and related substances were also evaluated. The results showed that the hydrolysis impurity H levels in the inverted stability samples were significantly lower than those of the upright samples in the long-term stability test, and the interaction between neck gaskets and formulations had no obvious effect on other critical quality attributes such as leak rate, delivered dose per actuation, FPD, and medication actuations per container, which were consistent with the standard of the 2020 edition of Chinese pharmacopoeia.
The therapeutic effects of Jingshu Keli(or Jingshu granules) on cervical spondylotic myelopathy(CSM) have been substantiated in clinical practice. Its main active constituents are notoginsenoside R1(1), ginsenoside Rg1(2), and ginsenoside Rb1(3). This study established an ultra-performance liquid chromatography-mass spectrometry(UPLC-MS) method for determination of the concentrations of 1, 2, and 3 in plasma of rats with CSM, then the pharmacokinetic characteristics of 1, 2, and 3 in the rats were investigated. The results showed that after oral gavage administration of Jingshu Keli to the rat, the plasma concentration of 1 was low(<8.892 ng/mL); the cmax, AUC0→t and t1/2 for 2 and 3 were(27.75±4.13) and(123.60±8.56)ng/mL, (255.41±38.59) and(1 344.32±122.52)h·ng·mL–1,(11.97±3.75) and(14.54±2.71)h, respectively. This detection method was sensitive and reliable, and was suitable for the pharmacokinetic study of 1, 2, and 3 in the rat model of CSM.
Nitrosamine compounds, due to the N-N=O bonds in their structure, can easily cause isomerization. When an HPLC method was used to analyze 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone(NNK), double peaks were observed. NNK and its isomers were effectively separated by PFP chromatographic column. Then a LC/MS method was used to investigate the secondary fragment ions of the two separated sample peaks. NMR investigation further confirmed that the impurity peaks in NNK belonged to its isomer, and the isomerization ratio range of NNK was determined by NMR quantitative method through variable temperature experiment. And the NMR results were confirmed through the temperature change test of HPLC. This study verified structure of the isomer through a variety of methods, which was conducive to the accurate analysis of NNK content and provided a theoretical basis for the detection of genotoxic impurities.
A method for determining the in vitro release of nifedipine(1) sustained-release tablets(Ⅰ) was established by using the reciprocating cylinder dissolution testing device, and parameters such as the volume of release medium, screen mesh size, immersion time, drip time, surfactant, defoamer, and reciprocating rate were investigated. The release curves of three batches of generic preparation samples with different release rates in vivo were determined under the optimized conditions of 900 mL medium without adding surfactants; the mesh size of upper screen and lower screen were 590 μm and 38 μm; 5 seconds immersion time; 60 seconds drip time; reciprocating rate 5 dip/min using multi-row mode of large dissolving cup method, and were compared with the release curves of reference preparations. The results showed that the determination method established in this study could distinguish generic preparation samples with different release rates, but the in vitro-in vivo correlation of the method was unsatisfactory.
A near infrared spectroscopy(NIRS) method was established to rapidly determine the content of paracetamol(1) in compound Ganmaoling granules to be packaged. Two hundred and thirty-two samples of compound Ganmaoling granules were collected and the content of 1 was determined by HPLC. The NIRS spectra of the granules were collected by integrating sphere diffuse reflection, and a quantitative analysis model of NIRS for 1 content was established using partial least squares(PLS). And different spectral bands, principal factor numbers, and preprocessing methods were investigated to optimize the model. The results showed that in the established optimal model, the root mean square error of cross validation(RMSECV) and R2 were 0.259 and 0.965 8, respectively. The root mean square error of prediction(RMSEP) and R value of the validation set were 0.253 and 0.999 2, respectively. The above experiment confirmed that the combination of NIRS and PLS could be successfully applied to monitor 1 content in the the compound Ganmaoling granules to be packaged. The established near infrared rapid detection method has the advantages of good model performance, high prediction accuracy, quick analysis, and non-destructive testing. The application of this method can significantly improve the production and circulation efficiency of compound Ganmaoling granules.